NASDAQ | ETF
The fund will normally invest at least 90% of its net assets (including investment borrowings) in the securities that comprise the index.
The index is designed to provide exposure toU. S. companies comprising the pharmaceutical sector that have been selected based upon their liquidity and ranking.
It is non-diversified.
Top 20 Holdings
| Asset | Name | Sector | Industry | Weight |
|---|---|---|---|---|
| BMY | Bristol-Myers Squibb Company | Healthcare | Drug Manufacturers - General | 7.67% |
| ABBV | AbbVie Inc | Healthcare | Drug Manufacturers - General | 7.58% |
| MRK | Merck & Company Inc | Healthcare | Drug Manufacturers - General | 7.26% |
| JNJ | Johnson & Johnson | Healthcare | Drug Manufacturers - General | 7.13% |
| PFE | Pfizer Inc | Healthcare | Drug Manufacturers - General | 7.13% |
| AMGN | Amgen Inc | Healthcare | Drug Manufacturers - General | 3.83% |
| GILD | Gilead Sciences Inc | Healthcare | Drug Manufacturers - General | 3.74% |
| ZTS | Zoetis Inc | Healthcare | Drug Manufacturers - Specialty & Generic | 3.72% |
| UTHR | United Therapeutics Corporation | Healthcare | Drug Manufacturers - Specialty & Generic | 3.68% |
| BIIB | Biogen Inc | Healthcare | Drug Manufacturers - General | 3.61% |
| VTRS | Viatris Inc | Healthcare | Drug Manufacturers - Specialty & Generic | 3.58% |
| REGN | Regeneron Pharmaceuticals Inc | Healthcare | Biotechnology | 3.39% |
| LLY | Eli Lilly and Company | Healthcare | Drug Manufacturers - General | 3.36% |
| JAZZ | Jazz Pharmaceuticals PLC | Healthcare | Biotechnology | 3.35% |
| OGN | Organon & Co | Healthcare | Drug Manufacturers - General | 2.63% |
| CRL | Charles River Laboratories | Healthcare | Diagnostics & Research | 1.95% |
| EXEL | Exelixis Inc | Healthcare | Biotechnology | 1.91% |
| MEDP | Medpace Holdings Inc | Healthcare | Diagnostics & Research | 1.74% |
| ELAN | Elanco Animal Health | Healthcare | Drug Manufacturers - Specialty & Generic | 1.63% |
| ILMN | Illumina Inc | Healthcare | Diagnostics & Research | 1.58% |